Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 2001 - 2100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2001 | 24824755 |
HU |
81 | 2 |
Death, Urinary tract infection, General physical health deterioration, Renal impairment, |
||||
ENOXAPARIN SODIUM, CLOPIDOGREL BISULFATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FUROSEMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, BISOPROLOL FUMARATE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 2002 | 24824851 |
CA |
40 | 2 |
Drug ineffective, Liver injury, Blood cholesterol increased, Live birth, Dizziness, Back injury, Arthralgia, Nausea, Anti-cyclic citrullinated peptide antibody positive, Condition aggravated, Asthenia, Irritable bowel syndrome, Glossodynia, Hepatic enzyme increased, Hypoaesthesia, Bursitis, Lip dry, Grip strength decreased, Muscle injury, Finger deformity, Pneumonia, Off label use, Facet joint syndrome, Drug-induced liver injury, Hepatitis, Alopecia, Gastrointestinal disorder, Confusional state, Pemphigus, C-reactive protein increased, Muscle spasms, Peripheral swelling, Helicobacter infection, Memory impairment, Epilepsy, Peripheral venous disease, Musculoskeletal stiffness, General physical health deterioration, Neck pain, Insomnia, Obesity, Headache, Pericarditis, Dry mouth, Pain in extremity, Migraine, Depression, Abdominal pain upper, Ill-defined disorder, Drug hypersensitivity, Fatigue, Folliculitis, Coeliac disease, Gait inability, Hypertension, Duodenal ulcer perforation, Diarrhoea, Maternal exposure during pregnancy, Injection site reaction, Abdominal distension, Intentional product use issue, Pain, Nail disorder, Onychomadesis, Blepharospasm, Lower respiratory tract infection, Musculoskeletal pain, Night sweats, Exposure during pregnancy, Onychomycosis, Nasopharyngitis, C-reactive protein abnormal, Malaise, Dyspepsia, Dyspnoea, Hand deformity, Fibromyalgia, Lung disorder, Arthropathy, Contraindicated product administered, Joint swelling, Drug intolerance, Adverse reaction, Injury, Joint range of motion decreased, Hypersensitivity, Osteoarthritis, Fall, Abdominal discomfort, Paraesthesia, Liver function test increased, Hypercholesterolaemia, Mobility decreased, Infusion related reaction, Impaired healing, Blister, Inflammation, Breast cancer stage III, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CANDESARTAN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ACETAMINOPHEN AND CODEINE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, SULFASALAZINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BOTULINUM TOXIN TYPE A, VITAMIN C, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BUPRENORPHINE, BUPRENORPHINE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, SECUKINUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, NICOTINAMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXYCODONE, OXYCODONE, RANITIDINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, MEPOLIZUMAB, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, GOLD, GOLD, GOLD, GOLD, RAMIPRIL, RAMIPRIL, RAMIPRIL, ERGOCALCIFEROL, ERGOCALCIFEROL, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, INFLIXIMAB, PREDNISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRAMADOL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, MIRABEGRON, MIRABEGRON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2003 | 24824866 |
US |
2 | |
General physical health deterioration, |
||||
NATALIZUMAB, |
||||
| 2004 | 24825680 |
US |
62 | 1 |
General physical health deterioration, Incorrect route of product administration, |
||||
RISPERIDONE, |
||||
| 2005 | 24825748 |
US |
2 | |
Disability, Infestation, Rheumatoid arthritis, Vomiting, General physical health deterioration, Unevaluable event, |
||||
ADALIMUMAB, |
||||
| 2006 | 24825869 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2007 | 24825870 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2008 | 24826009 |
FR |
83 | 1 |
General physical health deterioration, Acute kidney injury, Nausea, Decreased appetite, Diarrhoea, Pruritus, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 2009 | 24826074 |
DE |
79 | 2 |
Chronic kidney disease, Blood creatinine increased, Asthenia, Nephrolithiasis, Glomerular filtration rate decreased, General physical health deterioration, Leukopenia, Acute kidney injury, Thrombocytopenia, Nephrolithiasis, Cardiac failure congestive, Neutropenia, Osteoarthritis, Osteoarthritis, Renal impairment, Nausea, Vomiting, Hyponatraemia, Concomitant disease aggravated, Hypertension, Atrial fibrillation, Cardiac failure, Anaemia, Electrocardiogram QT prolonged, Urinary retention, Blood glucose increased, Eastern Cooperative Oncology Group performance status worsened, Bronchitis, Cystitis, Infection, Blood thyroid stimulating hormone increased, C-reactive protein increased, Pleural effusion, Urinary tract infection, Blood pressure increased, Oedema peripheral, Dry skin, Dyspnoea, Product use in unapproved indication, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, |
||||
| 2010 | 24826801 |
CA |
40 | 2 |
Hypertension, Weight increased, Wheezing, Wound infection, Pain, Migraine, Nasopharyngitis, Impaired healing, Hypersensitivity, Hypercholesterolaemia, Pain in extremity, Irritable bowel syndrome, Mobility decreased, Liver injury, Lung disorder, Obesity, Nausea, Helicobacter infection, Joint range of motion decreased, Pericarditis, Pneumonia, Onychomadesis, Pemphigus, Liver function test increased, Memory impairment, Onychomycosis, Hepatic enzyme increased, Lip dry, Intentional product use issue, Ill-defined disorder, Night sweats, Injection site reaction, Inflammation, Nail disorder, Lower respiratory tract infection, Insomnia, Osteoarthritis, Injury, Joint swelling, Musculoskeletal pain, Muscle injury, Peripheral swelling, Peripheral venous disease, Malaise, Muscle spasms, Hepatitis, Musculoskeletal stiffness, Neck pain, Paraesthesia, Infusion related reaction, Hypoaesthesia, Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Bronchitis, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Live birth, Maternal exposure during pregnancy, Muscular weakness, Product label confusion, Overdose, Underdose, Wound, Off label use, Eye injury, Loss of personal independence in daily activities, Product use issue, Psoriasis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Skin reaction, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Tachycardia, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Type 2 diabetes mellitus, Ulcer haemorrhage, Upper respiratory tract infection, Vomiting, White blood cell count decreased, Gastrooesophageal reflux disease, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SULFASALAZINE, MINOCYCLINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, MIRABEGRON, RANITIDINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, SECUKINUMAB, SECUKINUMAB, AZATHIOPRINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LAMOTRIGINE, LAMOTRIGINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, NICOTINAMIDE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ERENUMAB-AOOE, ERENUMAB-AOOE, MEPOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, RAMIPRIL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TRAMADOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CANDESARTAN, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, PHENYLEPHRINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERGOCALCIFEROL, TOFACITINIB, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, SARILUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, VITAMIN C, APREMILAST, CERTOLIZUMAB PEGOL, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 2011 | 24827296 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2012 | 24827773 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2013 | 24827775 |
DE |
||
Epstein-Barr virus infection reactivation, Pyrexia, General physical health deterioration, C-reactive protein increased, Iron deficiency anaemia, Oedema mucosal, Diarrhoea haemorrhagic, Drug ineffective, |
||||
UPADACITINIB, |
||||
| 2014 | 24827794 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2015 | 24827823 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2016 | 24827839 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2017 | 24827962 |
JP |
70 | 1 |
General physical health deterioration, Cholangitis acute, Pneumothorax, Cholecystitis acute, |
||||
LENVATINIB, LENVATINIB, |
||||
| 2018 | 24828061 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2019 | 24828122 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2020 | 24828368 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2021 | 24828375 |
US |
81 | 2 |
General physical health deterioration, Respiratory failure, Acute pulmonary oedema, Syncope, Fall, Weight decreased, Drug tolerance decreased, Therapy non-responder, |
||||
TREPROSTINIL, TREPROSTINIL, APIXABAN, AZATHIOPRINE, EMPAGLIFLOZIN, MAGNESIUM OXIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, MAGNESIUM GLYCINATE, MONTELUKAST SODIUM, MONTELUKAST, RIOCIGUAT, OXYGEN, 0XYGEN, SPIRONOLACTONE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, |
||||
| 2022 | 24830094 |
78 | 1 | |
Drug intolerance, General physical health deterioration, |
||||
| 2023 | 24816945 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2024 | 24816952 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2025 | 24817005 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2026 | 24817052 |
US |
2 | |
Mobility decreased, General physical health deterioration, Feeling abnormal, Hypoaesthesia, |
||||
NATALIZUMAB, |
||||
| 2027 | 24817195 |
SG |
57 | 1 |
General physical health deterioration, Nausea, Fatigue, Abdominal distension, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 2028 | 24817287 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2029 | 24817536 |
PL |
||
Death, Immune-mediated lung disease, COVID-19 pneumonia, Pneumonia influenzal, Tumour inflammation, General physical health deterioration, Off label use, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, PREDNISONE, |
||||
| 2030 | 24817567 |
US |
79 | 1 |
Drug intolerance, Renal impairment, General physical health deterioration, |
||||
DOXORUBICIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, |
||||
| 2031 | 24817910 |
US |
||
Norovirus infection, Ill-defined disorder, General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2032 | 24817938 |
CA |
76 | 2 |
General physical health deterioration, Rheumatoid arthritis, Inappropriate schedule of product administration, Accidental overdose, |
||||
METHOTREXATE SODIUM, |
||||
| 2033 | 24818097 |
US |
70 | 1 |
General physical health deterioration, Neutrophil count decreased, Hypotension, |
||||
FILGRASTIM, CAPECITABINE, OXALIPLATIN, URIDINE TRIACETATE, |
||||
| 2034 | 24818219 |
IN |
75 | 1 |
Hepatic function abnormal, Feeding disorder, General physical health deterioration, Asthenia, Hepatic cancer, |
||||
ATEZOLIZUMAB, |
||||
| 2035 | 24818224 |
56 | 2 | |
Therapeutic response decreased, Pain in extremity, Musculoskeletal stiffness, Alanine aminotransferase increased, Hepatic enzyme increased, Hepatic function abnormal, Liver function test increased, Arthropathy, Dry eye, Dry mouth, Finger deformity, General physical health deterioration, Hand deformity, Joint stiffness, Joint swelling, Night sweats, Pain, Peripheral swelling, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, BISOPROLOL FUMARATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, DESOXIMETASONE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2036 | 24818515 |
US |
63 | 2 |
Asthenia, Hypophagia, Feeling abnormal, Food refusal, Somnolence, Biliary obstruction, Pancreatic carcinoma, General physical health deterioration, Loss of consciousness, Blood pressure abnormal, Malaise, |
||||
RIOCIGUAT, RIOCIGUAT, RIOCIGUAT, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, SPIRONOLACTONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MACITENTAN, OXYGEN, 0XYGEN, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 2037 | 24818643 |
CA |
44 | 2 |
Duodenal ulcer perforation, Hypoaesthesia, Gait disturbance, C-reactive protein abnormal, Grip strength decreased, Hypertension, Asthma, Adjustment disorder with depressed mood, Frequent bowel movements, Confusional state, Folliculitis, Drug hypersensitivity, General physical health deterioration, Fibromyalgia, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Foot deformity, Bone erosion, Crohn^s disease, Glossodynia, Exostosis, Dyspnoea, Hand deformity, Arthropathy, Abdominal discomfort, Ear infection, Grip strength, Infection, Breast cancer stage III, Colitis ulcerative, Impaired healing, Discomfort, Hepatic cirrhosis, Delirium, Fatigue, Dislocation of vertebra, Abdominal pain, Ill-defined disorder, Dry mouth, Bursitis, Abdominal pain upper, Feeling hot, Deep vein thrombosis postoperative, Amnesia, Arthritis, Anxiety, Depression, Hypersensitivity, Decreased appetite, Condition aggravated, Dyspepsia, Asthenia, Blood cholesterol increased, Dizziness, Headache, Helicobacter infection, Autoimmune disorder, Gastrointestinal disorder, Arthralgia, Chest pain, Facet joint syndrome, Hepatic enzyme increased, Hypercholesterolaemia, Diarrhoea, Blister, Confusional state, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, FLUOROMETHOLONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, RITUXIMAB, RITUXIMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, PREGABALIN, ERGOCALCIFEROL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CAFFEINE, CAFFEINE, USTEKINUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LANSOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOSAPREPITANT DIMEGLUMINE, AZATHIOPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MELOXICAM, PREDNISONE, PREDNISONE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PREDNISONE, HYALURONIDASE, PIROXICAM, APREMILAST, APREMILAST, APREMILAST, LANSOPRAZOLE, ETANERCEPT, ETANERCEPT, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LISINOPRIL, LORAZEPAM, LISINOPRIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ERYTHROMYCIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MAGNESIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RAMIPRIL, LORAZEPAM, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, MESALAMINE, INFLIXIMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, CALCIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 2038 | 24819086 |
57 | 2 | |
Interstitial lung disease, Hepatic cytolysis, Acute kidney injury, Pancytopenia, Odynophagia, Decreased appetite, Respiratory failure, Pneumonia haemophilus, Toxicity to various agents, General physical health deterioration, Cheilitis, Bordetella infection, |
||||
METHOTREXATE SODIUM, ATOVAQUONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FOLIC ACID, AMLODIPINE, CANDESARTAN, |
||||
| 2039 | 24819244 |
GB |
2 | |
Intestinal haemorrhage, Rash pruritic, General physical health deterioration, Cystitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 2040 | 24819476 |
JP |
74 | 2 |
General physical health deterioration, Malaise, |
||||
| 2041 | 24819972 |
US |
1 | |
Death, General physical health deterioration, |
||||
BREXPIPRAZOLE, |
||||
| 2042 | 24820118 |
CH |
81 | 2 |
General physical health deterioration, |
||||
| 2043 | 24820145 |
18 | 1 | |
Sexual dysfunction, Cognitive disorder, Mood swings, Sensory loss, General physical health deterioration, |
||||
ESCITALOPRAM, CITALOPRAM, VILAZODONE HYDROCHLORIDE, |
||||
| 2044 | 24820182 |
BR |
69 | 1 |
Overdose, General physical health deterioration, Malaise, Nausea, Vomiting, Headache, |
||||
BORTEZOMIB, BORTEZOMIB, |
||||
| 2045 | 24820294 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2046 | 24820586 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Bursitis, Coeliac disease, Condition aggravated, Decreased appetite, Drug intolerance, Drug-induced liver injury, Dyspepsia, Exposure during pregnancy, Fatigue, Folliculitis, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Inflammation, Insomnia, Irritable bowel syndrome, Joint swelling, Live birth, Malaise, Maternal exposure during pregnancy, Mobility decreased, Musculoskeletal stiffness, Nail disorder, Off label use, Product label confusion, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ATOMOXETINE, AZATHIOPRINE SODIUM, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 2047 | 24820657 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2048 | 24820697 |
CA |
59 | 2 |
Alopecia, Discomfort, Dizziness, Drug hypersensitivity, Drug intolerance, Ear infection, Foot deformity, General physical health deterioration, Glossodynia, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Infection, Infusion related reaction, Laryngitis, Osteoporosis, Pericarditis, Pneumonia, Rash, Red blood cell sedimentation rate increased, Retinitis, Visual impairment, Wound, |
||||
SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, QUETIAPINE FUMARATE, QUETIAPINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CYCLOSPORINE, AMLODIPINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, SULFASALAZINE, BUPROPION HYDROCHLORIDE, CAFFEINE CITRATE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, BUPROPION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LISINOPRIL, CALCIUM GLUCONATE, HYDROMORPHONE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, LORAZEPAM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2049 | 24821853 |
US |
57 | 1 |
Dyspnoea, General physical health deterioration, Injection site pain, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, TESTOSTERONE CYPIONATE, BETAMETHASONE DIPROPIONATE, QUETIAPINE FUMARATE, QUETIAPINE, OMEPRAZOLE MAGNESIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 2050 | 24822237 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2051 | 24822246 |
CA |
40 | 2 |
Breast cancer stage III, Duodenal ulcer perforation, Coeliac disease, Drug-induced liver injury, Epilepsy, Hepatitis, Liver injury, Lower respiratory tract infection, Pemphigus, Pericarditis, Pneumonia, Finger deformity, Hand deformity, Psoriatic arthropathy, Rheumatoid arthritis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Dyspepsia, Dyspnoea, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Peripheral swelling, Peripheral venous disease, Abdominal discomfort, Abdominal distension, Gastrooesophageal reflux disease, Rash, Contusion, Stomatitis, Swelling, Muscular weakness, Taste disorder, Weight increased, Vomiting, Wheezing, Wound, Wound infection, Synovitis, Urticaria, Drug ineffective, Contraindicated product administered, Intentional product use issue, Off label use, Exposure during pregnancy, Maternal exposure during pregnancy, Product label confusion, Product use in unapproved indication, Product use issue, Product quality issue, Product quality issue, |
||||
MIRABEGRON, MIRABEGRON, MIRABEGRON, DEXTROMETHORPHAN, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB-ADAZ, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, |
||||
| 2052 | 24822380 |
US |
61 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 2053 | 24822383 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2054 | 24822385 |
US |
||
Cerebrovascular accident, General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2055 | 24822386 |
JP |
76 | 1 |
General physical health deterioration, Nausea, |
||||
ZOLBETUXIMAB, NIVOLUMAB, OXALIPLATIN, OXALIPLATIN, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, FLUOROURACIL, |
||||
| 2056 | 24812579 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2057 | 24812973 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2058 | 24812982 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2059 | 24813473 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2060 | 24813721 |
US |
61 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 2061 | 24813991 |
FR |
||
Hepatocellular carcinoma, General physical health deterioration, Off label use, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 2062 | 24814103 |
CA |
44 | 2 |
Breast cancer stage III, Lower respiratory tract infection, Hypoaesthesia, Exposure during pregnancy, Joint range of motion decreased, Dry mouth, Rectal haemorrhage, Ill-defined disorder, Grip strength decreased, Foot deformity, Gastrointestinal disorder, Impaired healing, Insomnia, Arthralgia, Sleep disorder due to a general medical condition, Frequent bowel movements, Amnesia, Blister, Rheumatoid arthritis, Anxiety, C-reactive protein abnormal, Bone erosion, Facet joint syndrome, Exostosis, Fibromyalgia, Dislocation of vertebra, Abdominal pain, Glossodynia, Muscular weakness, Pericarditis, Autoimmune disorder, Liver injury, Drug hypersensitivity, Maternal exposure during pregnancy, Dyspnoea, Bursitis, Alopecia, Porphyria acute, Folliculitis, Pancreatitis, Delirium, Asthenia, Chest pain, Respiratory disorder, Ear infection, Deep vein thrombosis postoperative, Discomfort, Gait disturbance, Dizziness, Hypersensitivity, Hypertension, Arthritis, Injury, Headache, Lupus-like syndrome, Asthma, Decreased appetite, Diarrhoea, Contusion, Lupus vulgaris, Hepatic cirrhosis, Duodenal ulcer perforation, Infection, Confusional state, Psoriatic arthropathy, Joint stiffness, Pneumonia, Arthropathy, Grip strength, Hepatic enzyme increased, Depression, Inflammation, Hand deformity, Retinitis, Condition aggravated, Irritable bowel syndrome, Crohn^s disease, Drug tolerance decreased, Dyspepsia, Abdominal pain upper, Liver disorder, Pulmonary fibrosis, Hypercholesterolaemia, Infusion related reaction, General physical health deterioration, Colitis ulcerative, Anti-cyclic citrullinated peptide antibody positive, Pemphigus, Adjustment disorder with depressed mood, Abdominal discomfort, Blood cholesterol increased, Fatigue, Feeling hot, Helicobacter infection, |
||||
ALBUTEROL SULFATE, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CAFFEINE, CAFFEINE, ABATACEPT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, AZATHIOPRINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, FLUOROMETHOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, VITAMIN C, LORAZEPAM, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 2063 | 24814353 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2064 | 24814363 |
US |
||
Dementia, General physical health deterioration, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 2065 | 24814467 |
US |
68 | 2 |
Product dose omission issue, General physical health deterioration, |
||||
NATALIZUMAB, |
||||
| 2066 | 24814572 |
US |
65 | 2 |
Pain, General physical health deterioration, |
||||
ABATACEPT, |
||||
| 2067 | 24814897 |
JP |
90 | 2 |
Hepatic function abnormal, Marasmus, Malnutrition, Hypoalbuminaemia, Pleural effusion, General physical health deterioration, Hypoglycaemia, Blood pressure decreased, Dehydration, Renal impairment, Hypophagia, Ascites, Pericardial effusion, Hepatic mass, Renal cyst, Pyelocaliectasis, Gallbladder enlargement, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, DAPAGLIFLOZIN, TRANEXAMIC ACID, LUBIPROSTONE, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 2068 | 24815142 |
36 | 2 | |
Migraine, Apathy, Withdrawal syndrome, Amnesia, Autonomic nervous system imbalance, Visual impairment, Dysphagia, Sexual dysfunction, Language disorder, Injury, Illness, Nonspecific reaction, Tinnitus, Confusional state, Illness, Vertigo, Oscillopsia, Electroencephalogram abnormal, Cognitive disorder, Arteriosclerosis, Lumbar puncture abnormal, Mental disorder, General physical health deterioration, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 2069 | 24815328 |
US |
58 | 1 |
Arthralgia, General physical health deterioration, Gait disturbance, |
||||
ABATACEPT, |
||||
| 2070 | 24815393 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2071 | 24815578 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2072 | 24815584 |
DE |
2 | |
Sleep disorder, Sudden onset of sleep, Somnolence, Disturbance in attention, General physical health deterioration, Gamma-glutamyltransferase increased, |
||||
PANTOPRAZOLE, SIMVASTATIN, AMLODIPINE, BISOPROLOL FUMARATE, APIXABAN, TORSEMIDE, PREGABALIN, |
||||
| 2073 | 24816048 |
US |
70 | 1 |
Death, Bleeding varicose vein, Hepatic encephalopathy, Hepatitis, General physical health deterioration, Urinary tract infection pseudomonal, Cholangitis, Biliary dilatation, Cholestasis, Drug effective for unapproved indication, Off label use, |
||||
PREDNISONE, AZATHIOPRINE, |
||||
| 2074 | 24816160 |
RO |
76 | 1 |
Death, Pulmonary mass, Hilar lymphadenopathy, Lymphadenopathy mediastinal, Aortic arteriosclerosis, Liver injury, Diarrhoea, Weight decreased, Asthenia, Hepatic cytolysis, Pain, Muscle contractions involuntary, Thrombocytopenia, Pyrexia, Chills, Cholestasis, Biliary dilatation, Leukocytosis, Neutrophilia, Inflammation, General physical health deterioration, Off label use, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 2075 | 24816183 |
CA |
||
Full blood count decreased, Metastases to central nervous system, General physical health deterioration, Asthenia, Dysuria, Urinary tract infection, |
||||
OSIMERTINIB, OSIMERTINIB, OSIMERTINIB, |
||||
| 2076 | 24816316 |
CA |
40 | 2 |
Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Malaise, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Helicobacter infection, Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Live birth, Maternal exposure during pregnancy, Hepatic enzyme increased, Hypotension, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, AZATHIOPRINE, CANDESARTAN, CANDESARTAN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CALCIUM CARBONATE, ANTACID, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, VITAMIN C, |
||||
| 2077 | 24816385 |
CA |
82 | 2 |
Malaise, Eye swelling, Swelling face, Abdominal discomfort, Dizziness, Diarrhoea, Vision blurred, Brain fog, Dyspnoea, Pain, General physical health deterioration, Eye infection, Headache, Intentional product use issue, Therapy cessation, |
||||
BRODALUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 2078 | 24816664 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2079 | 24816886 |
US |
41 | 2 |
General physical health deterioration, Dyspnoea, Influenza, Catheter site haemorrhage, |
||||
TREPROSTINIL, TREPROSTINIL, SERTRALINE HYDROCHLORIDE, POTASSIUM CHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, DRONABINOL, AMBRISENTAN, FOLIC ACID, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, APIXABAN, GABAPENTIN, LEVETIRACETAM, CLONAZEPAM, CEFAZOLIN SODIUM, FUROSEMIDE, AMLODIPINE BESYLATE, ONDANSETRON HYDROCHLORIDE, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, SEMAGLUTIDE, |
||||
| 2080 | 24808038 |
US |
||
General physical health deterioration, Gait disturbance, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2081 | 24808085 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2082 | 24808124 |
BR |
||
Pneumonia, Hypoacusis, Therapeutic response decreased, Fistula, General physical health deterioration, Therapeutic response changed, Product dose omission issue, Intentional product use issue, Overdose, Contraindicated product administered, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, VERAPAMIL HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, BUDESONIDE, ACETYLCYSTEINE, BRIMONIDINE TARTRATE, CLONAZEPAM, |
||||
| 2083 | 24808314 |
CO |
65 | 2 |
Influenza, Bronchitis, Deafness, Aphonia, Speech disorder, COVID-19, Abdominal pain upper, Constipation, Malaise, General physical health deterioration, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 2084 | 24808327 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2085 | 24808532 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2086 | 24808549 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2087 | 24808598 |
US |
||
Food intolerance, Nausea, General physical health deterioration, Mental disorder, Eosinophilic oesophagitis, Hyperhidrosis, Fatigue, Food intolerance, Dairy intolerance, Feeling hot, Feelings of worthlessness, |
||||
BUDESONIDE, |
||||
| 2088 | 24808602 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 2089 | 24808725 |
AT |
1 | |
Cognitive disorder, Dehydration, General physical health deterioration, Delirium, Mental disorder, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 2090 | 24808754 |
FR |
90 | 1 |
Interstitial lung disease, Loss of personal independence in daily activities, Cognitive disorder, Fall, Disorientation, Decreased appetite, General physical health deterioration, |
||||
EZETIMIBE, SILODOSIN, ACEBUTOLOL HYDROCHLORIDE, |
||||
| 2091 | 24808893 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2092 | 24808949 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 2093 | 24809048 |
US |
30 | 2 |
General physical health deterioration, Pain, |
||||
ABATACEPT, |
||||
| 2094 | 24809315 |
US |
||
Dry skin, Pain, Epistaxis, Nasal congestion, Taste disorder, General physical health deterioration, Nasopharyngitis, Alopecia, Nocturia, Sinus disorder, Glycosylated haemoglobin abnormal, Nasal dryness, Hot flush, Incorrect dose administered, |
||||
RELUGOLIX, DAROLUTAMIDE, |
||||
| 2095 | 24809343 |
US |
81 | 1 |
Multiple organ dysfunction syndrome, General physical health deterioration, Clostridium difficile infection, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, FIDAXOMICIN, NIVOLUMAB, PREDNISONE, |
||||
| 2096 | 24809598 |
JP |
80 | 2 |
General physical health deterioration, |
||||
AVACOPAN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BISOPROLOL FUMARATE, OMEGA-3-ACID ETHYL ESTERS, |
||||
| 2097 | 24809684 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect product administration duration, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, |
||||
| 2098 | 24810132 |
FR |
55 | 1 |
General physical health deterioration, C-reactive protein increased, Hyperleukocytosis, |
||||
PEMETREXED DISODIUM, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 2099 | 24810142 |
IT |
87 | 2 |
General physical health deterioration, |
||||
| 2100 | 24810209 |
DE |
2 | |
Sudden onset of sleep, Sleep disorder, Somnolence, Disturbance in attention, General physical health deterioration, Gamma-glutamyltransferase increased, |
||||
AMLODIPINE, BISOPROLOL FUMARATE, PANTOPRAZOLE, SIMVASTATIN, TORSEMIDE, APIXABAN, PREGABALIN, PREGABALIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28